SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000056
Filing Date
2021-03-17
Accepted
2021-03-17 09:07:32
Documents
79
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 10-Q gnbt013121form10q.htm 10-Q 1391707
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11916
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11886
4 EXHIBIT 32 ex32.htm EX-32 3834
11 GRAPHIC image_001.gif GRAPHIC 3785
  Complete submission text file 0001607062-21-000056.txt   5385088

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20210131.xml EX-101.INS 712493
6 XBRL SCHEMA FILE gnbt-20210131.xsd EX-101.SCH 67202
7 XBRL CALCULATION FILE gnbt-20210131_cal.xml EX-101.CAL 68504
8 XBRL DEFINITION FILE gnbt-20210131_def.xml EX-101.DEF 263035
9 XBRL LABEL FILE gnbt-20210131_lab.xml EX-101.LAB 386417
10 XBRL PRESENTATION FILE gnbt-20210131_pre.xml EX-101.PRE 357258
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 21748740
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences